USDA SCRI funds PAPAS research: Potatoes and Pests – Actionable Science Against Nematodes – Potato News Today potatonewstoday.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from potatonewstoday.com Daily Mail and Mail on Sunday newspapers.
Nova Mentis Launches Autism Microbiome Study in the United States
News provided by
Share this article
Nova Mentis Life Science Corp. (CSE: NOVA) (FSE: HN3Q) (OTCQB: NMLSF)
( NOVA or the Company ), a leader in the development of psilocybin and other entheogens, is pleased to announce the launch of its US-based Observational Study NM-101:
Microbiotic Diversity in Autism Spectrum Disorder (ASD): Improving Diagnostics by Differentiating Subtypes. NOVA s mission is to discover more precise ways to diagnose and treat autism spectrum disorder (ASD), an unmet medical need, stated Julia V. Perederiy, PhD, NOVA s Lead Scientist and Principal Investigator on the study.